A 52-year-old Aboriginal man from a remote community with known rheumatic heart disease (moderate mitral regurgitation) presents for review. He had documented acute rheumatic fever at age 18 years. He has been adherent with intramuscular benzathine benzylpenicillin G every 4 weeks since diagnosis. What is the recommended ongoing strategy regarding secondary prophylaxis?